Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers

Grace Farhat(University of Pittsburgh), Joyce Lee(Inserm), F. A. Hubbell(University of California, Irvine), Andrew Huang(Washington University in St. Louis), Jane A. Cauley(University of Pittsburgh), Dorothy S. Lane(Stony Brook School), Thomas E. Rohan(Albert Einstein College of Medicine), Barbara B. Cochrane(University of Washington), JoAnn E. Manson(Brigham and Women's Hospital), S. R. Cummings(University of California, San Francisco), Rowan T. Chlebowski(The Ohio State University), Neeta Parimi(California Pacific Medical Center), Mara Z. Vitolins(Wake Forest University)
JNCI Journal of the National Cancer Institute
February 17, 2011
10.1093/jnci/djr031
Cited by 114

Related Papers

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
|JAMA|2003|1.2k
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
|New England Journal of Medicine|2006|985
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833